Aspire Biopharma Holdings, Inc., to Present at Sidoti Virtual Investor Conference August 20
-
Spotify says piracy activists hacked its music catalogue
-
Winter Olympics organisers resolve snow problem at ski site
-
Fuming Denmark summons US ambassador over Greenland envoy
-
UK's street artist Banksy unveils latest mural in London
-
Rugby players lose order challenge in brain injury claim
-
UK singer Chris Rea dies at 74, days before Christmas
-
Last of kidnapped Nigerian pupils handed over, government says
-
Zambia strike late to hold Mali in AFCON opener
-
Outcry follows CBS pulling program on prison key to Trump deportations
-
Sri Lanka cyclone caused $4.1 bn damage: World Bank
-
Billionaire Ellison offers personal guarantee for son's bid for Warner Bros
-
Tech stocks lead Wall Street higher, gold hits fresh record
-
Telefonica to shed around 5,500 jobs in Spain
-
McCullum wants to stay as England coach despite Ashes drubbing
-
EU slams China dairy duties as 'unjustified'
-
Italy fines Apple nearly 100 mn euros over app privacy feature
-
America's Cup switches to two-year cycle
-
Jesus could start for Arsenal in League Cup, says Arteta
-
EU to probe Czech aid for two nuclear units
-
Strauss says sacking Stokes and McCullum will not solve England's Ashes woes
-
Noel takes narrow lead after Alta Badia slalom first run
-
Stocks diverge as rate hopes rise, AI fears ease
-
Man City players face Christmas weigh-in as Guardiola issues 'fatty' warning
-
German Christmas markets hit by flood of fake news
-
Liverpool fear Isak has broken leg: reports
-
West Indies captain says he 'let the team down' in New Zealand Tests
-
Thailand says Cambodia agrees to border talks after ASEAN meet
-
Alleged Bondi shooters conducted 'tactical' training in countryside, Australian police say
-
Swiss court to hear landmark climate case against cement giant
-
Knicks' Brunson scores 47, Bulls edge Hawks epic
-
Global nuclear arms control under pressure in 2026
-
Asian markets rally with Wall St as rate hopes rise, AI fears ease
-
Jailed Malaysian ex-PM Najib loses bid for house arrest
-
Banned film exposes Hong Kong's censorship trend, director says
-
Duffy, Patel force West Indies collapse as NZ close in on Test series win
-
Australian state pushes tough gun laws, 'terror symbols' ban after shooting
-
A night out on the town during Nigeria's 'Detty December'
-
US in 'pursuit' of third oil tanker in Caribbean: official
-
CO2 soon to be buried under North Sea oil platform
-
Steelers edge Lions as Bears, 49ers reach playoffs
-
India's Bollywood counts costs as star fees squeeze profits
-
McCullum admits errors in Ashes preparations as England look to salvage pride
-
Pets, pedis and peppermints: When the diva is a donkey
-
'A den of bandits': Rwanda closes thousands of evangelical churches
-
Southeast Asia bloc meets to press Thailand, Cambodia on truce
-
As US battles China on AI, some companies choose Chinese
-
AI resurrections of dead celebrities amuse and rankle
-
SMX and Partners Push Gold Compliance Out of the Back Office and Into the Supply Chain
-
Jonathan Blum Launches Next-Generation Real Estate Brand Empowering Smart Investors in South Florida
-
International Symposium on Archaeology & The Bible IX to Feature Esteemed Voices in Biblical Studies and Archaeology
NYSE - LSE
Aspire Biopharma Holdings, Inc., to Present at Sidoti Virtual Investor Conference August 20
ESTERO, FL / ACCESS Newswire / August 14, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), developer of a multi-faceted patent-pending drug and supplement delivery technology, today announced that Kraig Higginson, Interim Chief Executive Officer of Aspire, will be presenting at the upcoming Sidoti Virtual Investor Conference on August 20 at 1:45 PM Eastern. Investors and other interested individuals may access the virtual presentation here: https://sidoti.zoom.us/webinar/register/WN_5UneWjXKTOuzgbB4wpeByg
One-on-One Meetings
Aspire will also host virtual one-on-ones with investors on Wednesday, August 20 and Thursday, August 21, 2025. To register for the presentation or one-on ones, visit https://sidoti.com/events.
A replay of the presentation will be available on the investor relations section of Aspire's website at https://ir.aspirebiolabs.com/events/
About Aspire Biopharma, Inc.
Aspire Biopharma has developed a patent-pending disruptive technology that can deliver supplements and drugs to the body rapidly and precisely with less negative impact to the system by going directly to the bloodstream and avoiding the gastrointestinal tract. For more information, please visit www.aspirebiolabs.com.
Aspire Biopharma Holdings, Inc.
Contact
PCG Advisory
Kevin McGrath
+1-646-418-7002
[email protected]
SOURCE: Aspire Biopharma Holdings, Inc.
View the original press release on ACCESS Newswire
P.Martin--AMWN